跳至主要内容
临床试验/CTRI/2021/09/036829
CTRI/2021/09/036829尚未招募2 期

Effect of Yoga-based Rehabilitation on pulmonary function in COVID-19 survivors with respiratory sequelae: A PROBE trial

All India Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2021年11月30日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
104
试验地点
1
主要终点
Pulmonary Function: Diffusion lung capacity for carbon monoxide (DLCO), Forced Vital capacity (FVC), Forced expiratory volume in first second (FEV1), Total lung capacity (TLC) using Pulmonary function test

研究概览

简要总结

Coronavirus disease recovered cases reveal the varying degrees of radiological abnormalities associated with the deterioration of the pulmonary function which could manifest in a cascade of cardiopulmonary consequences and abnormal lung function. Also, unprecedented change, fear, and uncertainty during the COVID era has implicated in emotional distress, psychosocial dysfunction, and a surge of mental health problems. Yoga improvement in pulmonary function, rehabilitation, Health-Related Quality of Life and reduces Anxiety & Depression, several types of research have demonstrated the benefits of yoga. The current study attempts to explore yoga-based rehabilitation using a validated and customized yoga module. Keeping this in consideration, a randomized controlled open-label, endpoint blind, a clinical trial is planned to evaluate Yoga therapy as an add-on to standard care in Post covid patients.The proposed study design is a prospective randomized open label blinded endpoint trial with 1:1 allocation ratio. The study participant may fall into the intervention arm will give Yoga for 30 mint for 12 weeks.outcome measures on Baseline, after 6 weeks and at the end of 12 weeks of study.

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, fixed
盲法
Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • •a)Known case of COVID patients with respiratory symptoms on screening (RT-PCR negative or 4 weeks to 8 weeks from the onset of first symptom) b)Patients with forced vital capacity(FVC)<80% c)Patients of both sex and age of18-75years d)Patients who are able and willing to practice any form of exercise when recruited under the study e)Patients who are not engaged in regular and structured yoga practice.

排除标准

  • •a)Patients with forced vital capacity FVC<40 % b)Previous pulmonary complications like severe asthma, COPD, bronchiectasis, interstitial lung disease(IL) c)Known cases of CAD with moderate to severe LV dysfunction, patients with a history of CV or neurodegenerative diseases.
  • •d)Lactating and pregnant women.
  • •e)Patients currently participating in any other clinical trials with intervention.

结局指标

主要结局

Pulmonary Function: Diffusion lung capacity for carbon monoxide (DLCO), Forced Vital capacity (FVC), Forced expiratory volume in first second (FEV1), Total lung capacity (TLC) using Pulmonary function test

时间窗: Baseline, after 6 weeks and at the end of 12 weeks

次要结局

  • Severity of dyspnea using UCSD Shortness of Breath Questionnaire.(Exercise capacity using 6-minute walk test)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验